Why We Don't Start With Stem Cells
The Science Behind the RegeneZone Method
By John A. Robinson, NMD
One of the biggest misconceptions in regenerative medicine is the belief that healing begins the moment stem cells or another biologic product are injected into an injured joint. While that may seem logical on the surface, my experience over nearly two decades in regenerative medicine has taught me that biology is far more complex than that.
If regeneration were simply about placing new cells into damaged tissue, every stem cell procedure would produce similar results. We know that isn't the case. Two patients can receive the exact same biologic product, prepared in the exact same way, yet have dramatically different outcomes. The question I've spent years asking is, Why?
The answer, I believe, lies not in the product itself, but in the biological environment into which that product is introduced.
A recently published review on Wharton's jelly-derived extracellular vesicles (EVs) adds further support to this concept. The authors describe how EVs exert many of their regenerative effects not by replacing damaged tissue, but by influencing cellular communication. These vesicles modulate inflammatory pathways, immune function, angiogenesis, cellular migration, and gene expression, helping reshape the biological environment before tissue repair occurs.¹
That concept is central to how I have developed the RegeneZone Method.
Regeneration Begins with Communication
One of the themes you'll hear me discuss repeatedly is that regeneration is fundamentally a communication process. Every tissue in the body is constantly exchanging information. Cells communicate through cytokines, growth factors, extracellular vesicles, hormones, neurotransmitters, and hundreds of other signaling molecules. When an injury becomes chronic, those conversations begin to change.
Instead of receiving signals that promote healing, the joint often becomes trapped in a cycle of chronic inflammation. Matrix metalloproteinases continue degrading cartilage, inflammatory cytokines remain elevated, oxidative stress accumulates, blood flow becomes impaired, and immune cells continue receiving messages that something is wrong. Under those conditions, even the highest quality regenerative products are entering an environment that is actively working against them.
I often explain this to patients using a construction analogy. If you wanted to rebuild a home after a tornado, you wouldn't begin by delivering lumber while the demolition crew was still knocking down walls. You would first stop the destruction, clear the debris, organize the workers, and prepare the site for reconstruction. Only then would you begin building.
The same principle applies to regenerative medicine. Before I ask the body to rebuild tissue, I want to make sure the environment is prepared to receive that regenerative signal.
Extracellular Vesicles: Nature's Biological Project Managers
Extracellular vesicles are one of the most exciting developments in regenerative medicine because they fundamentally change how we think about healing. These tiny membrane-bound particles are released naturally by cells and contain an extraordinary collection of biologically active molecules, including microRNA, messenger RNA, proteins, lipids, enzymes, cytokines, and growth factors. Their purpose is not to replace damaged tissue but to deliver instructions to neighboring cells.
The recent literature reinforces exactly that concept. Rather than acting as replacement cells, EVs function as sophisticated biological communicators that influence surrounding cells by regulating inflammation, immune responses, angiogenesis, oxidative stress, and tissue remodeling.¹⁻⁴
To me, this represents a major shift in regenerative medicine. We are moving away from the old idea that stem cells simply become new cartilage or tendon. Instead, we are beginning to appreciate that much of regeneration occurs because these biologic products restore communication between cells. They remind injured tissue how to heal.
Why We Often Use EVs Before Wharton's Jelly
This emerging science closely mirrors the treatment philosophy I have developed at RegeneZone. Rather than attempting to accomplish everything with a single injection, I believe regenerative medicine works best when it follows biology.
One of the principles of the RegeneZone Method is that we often introduce extracellular vesicles before placing Wharton's jelly into a damaged joint. My goal is to first calm the inflammatory environment, improve cellular communication, recruit the body's own repair mechanisms, and begin shifting the tissue toward a regenerative state. Once that process has begun, I believe the joint is better prepared to benefit from the structural support provided by Wharton's jelly.
Although the optimal clinical sequencing of extracellular vesicles and Wharton's jelly has not yet been established in randomized orthopedic trials, I believe regenerative medicine should increasingly follow the biology of healing. If extracellular vesicles help restore cellular communication and reduce a hostile inflammatory microenvironment, it is logical to first prepare the tissue for regeneration before introducing the structural matrix provided by Wharton's jelly. The growing body of mechanistic research continues to support this philosophy, and it is one of the reasons this sequence has become an important part of the RegeneZone Method.¹⁻⁴
Wharton's Jelly Is Much More Than Stem Cells
Another misconception I frequently encounter is that Wharton's jelly is simply another stem cell product. In reality, Wharton's jelly is a remarkably sophisticated extracellular matrix that contains hyaluronic acid, collagen, proteoglycans, growth factors, cytokines, and numerous bioactive molecules that support tissue organization and healing.
I often describe Wharton's jelly as the scaffold upon which regeneration occurs. If extracellular vesicles are responsible for organizing the construction crew and coordinating communication, Wharton's jelly provides the structural framework that allows new tissue to develop. These therapies are not competing with one another. They are performing different biological jobs that complement each other.
That distinction is important because regenerative medicine should never be viewed as a search for a single miracle product. It is about understanding how different biologic tools work together to recreate the conditions necessary for healing.
Communication Before Construction
When we examine how the body naturally repairs itself, we see that regeneration always follows a sequence. The immune system first recognizes injury, inflammatory pathways become activated, signaling molecules recruit additional cells, new blood vessels begin to develop, and only after those communication networks are established does tissue remodeling truly begin.
The RegeneZone Method is designed around that same biological sequence. Rather than forcing regeneration, my goal is to support the body's own healing process by working with the natural order in which repair occurs.
The RegeneZone Method
One of the defining characteristics of RegeneZone is that we treat regeneration as a process rather than a procedure. Every patient is unique, and every treatment plan is individualized, but our philosophy generally follows four biological phases.
The first phase focuses on reducing systemic inflammation. Before any regenerative procedure, we optimize the patient's biology through nutrition, metabolic health, hormone optimization when appropriate, targeted supplementation, peptide therapy, and other interventions designed to reduce chronic inflammatory burden. I have become increasingly convinced that patients heal better when their entire physiology is functioning more efficiently.
The second phase involves preparing the local tissue environment. This is where extracellular vesicles often play an important role. By improving cellular communication, modulating inflammation, and recruiting endogenous repair mechanisms, EVs help shift the injured tissue toward a regenerative state before more structural therapies are introduced.
The third phase is reconstruction. Once the biological environment has been optimized, Wharton's jelly provides the extracellular matrix, structural proteins, growth factors, and supportive architecture that help facilitate tissue repair. Rather than asking one product to accomplish every task, each therapy is used according to its biological strengths.
The final phase focuses on remodeling and long-term recovery. Healing continues for months after an injection. Physical therapy, progressive loading, proper nutrition, adequate protein intake, sleep optimization, hormone balance, peptide therapy, and continued lifestyle interventions all help guide the maturation of newly repaired tissue. In many ways, the injection itself is only the beginning of the regenerative process.
Regeneration Is an Ecosystem
Perhaps the most important lesson I have learned throughout my career is that regeneration is never created by a single product. Healing is the result of an entire biological ecosystem working together. Hormones, immune function, inflammation, circulation, mitochondrial health, nutrition, biomechanics, and cellular communication all influence the final outcome.
This is why I have never believed that regenerative medicine should revolve around asking which injection is "the best." The better question is how we create the ideal biological conditions that allow every regenerative therapy to perform at its highest potential.
That philosophy has become the foundation of the RegeneZone Method.
Looking Ahead
As regenerative medicine continues to evolve, I believe we will spend less time focusing on cells themselves and much more time understanding how cells communicate. The growing body of research surrounding extracellular vesicles supports what many experienced regenerative physicians have observed clinically for years: successful healing depends as much on restoring biological communication as it does on introducing regenerative materials.
At RegeneZone, I believe regeneration begins long before the injection. It begins by preparing the patient, optimizing the biological environment, restoring cellular communication, and then introducing the right regenerative therapies in the right sequence.
Healing is rarely the result of a single product or a single procedure. It is the culmination of thousands of coordinated biological events occurring in the proper order. My goal has always been to understand that order, respect it, and use it to help patients achieve the best outcomes possible.
Because in the end, successful regeneration isn't simply about adding new tissue. It's about creating the conditions that allow the body to remember how to heal itself.
References
Tilotta V, et al. Wharton's Jelly Mesenchymal Stromal Cell-Derived Extracellular Vesicles: Biological Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(18):8632. PMID: 42342653.
Khanh VC, et al. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles: Current Perspectives and Clinical Applications. Stem Cells International. 2021;2021:8843868.
Joerger-Messerli MS, et al. Human Wharton's Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways. Frontiers in Cell and Developmental Biology. 2021;9:622539.
Krishnan I, et al. Efficacy of Fetal Wharton's Jelly Mesenchymal Stem Cell-Derived Small Extracellular Vesicles: Quality Control and Therapeutic Applications. Biomolecules. 2025;15(1):44.
